1. Home
  2. LMB vs MGTX Comparison

LMB vs MGTX Comparison

Compare LMB & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

HOLD

Current Price

$81.26

Market Cap

960.5M

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$12.11

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMB
MGTX
Founded
1901
2015
Country
United States
United States
Employees
1400
N/A
Industry
Engineering & Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
960.5M
909.1M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
LMB
MGTX
Price
$81.26
$12.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$116.67
$24.57
AVG Volume (30 Days)
261.1K
780.8K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
25.68
33.02
EPS
0.36
N/A
Revenue
$646,804,000.00
$81,391,000.00
Revenue This Year
$15.96
$141.38
Revenue Next Year
$5.90
N/A
P/E Ratio
$227.53
N/A
Revenue Growth
24.68
144.57
52 Week Low
$65.08
$6.31
52 Week High
$154.04
$12.28

Technical Indicators

Market Signals
Indicator
LMB
MGTX
Relative Strength Index (RSI) 50.33 69.21
Support Level $79.99 $7.10
Resistance Level $85.46 $11.85
Average True Range (ATR) 4.35 0.63
MACD 0.30 0.22
Stochastic Oscillator 52.88 83.63

Price Performance

Historical Comparison
LMB
MGTX

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: